136 related articles for article (PubMed ID: 30024707)
1. Favourable long term effect of ursodeoxycholic acid treatment on congenital vanishing bile duct syndromes.
Karageorgos SA; Tzardi M; Stratakou S; Voumvouraki A; Notas G; Kouroumalis E
Acta Gastroenterol Belg; 2018; 81(2):330-332. PubMed ID: 30024707
[No Abstract] [Full Text] [Related]
2. Ursodeoxycholic acid treatment of vanishing bile duct syndromes.
Pusl T; Beuers U
World J Gastroenterol; 2006 Jun; 12(22):3487-95. PubMed ID: 16773706
[TBL] [Abstract][Full Text] [Related]
3. Ursodeoxycholic acid in the treatment of AIDS-associated cholangiopathy.
Castiella A; Iribarren JA; López P; Arrizabalaga J; Rodríguez F; von Wichmann MA; Arenas JI
Am J Med; 1997 Aug; 103(2):170-1. PubMed ID: 9274905
[No Abstract] [Full Text] [Related]
4. Drug-induced vanishing bile duct syndrome: response to ursodiol.
O'Brien CB; Shields DS; Saul SH; Reddy KR
Am J Gastroenterol; 1996 Jul; 91(7):1456-7. PubMed ID: 8678017
[No Abstract] [Full Text] [Related]
5. Application of ursodeoxycholic acid (UDCA) in the therapy of liver and biliary duct diseases in children.
Lebensztejn DM
Med Sci Monit; 2000; 6(3):632-6. PubMed ID: 11208384
[TBL] [Abstract][Full Text] [Related]
6. [Diseases of the intrahepatic bile duct: diagnosis and principles of treatment].
Chazouillères O; Wendum D
Gastroenterol Clin Biol; 2003 Mar; 27(3 Pt 1):307-18. PubMed ID: 12700519
[No Abstract] [Full Text] [Related]
7. Bile duct disorders.
Geubel AP; Sempoux C; Rahier J
Clin Liver Dis; 2003 May; 7(2):295-309. PubMed ID: 12879985
[TBL] [Abstract][Full Text] [Related]
8. Neonatal cholelithiasis in Down syndrome: Is hypothyroidism involved? A case-report.
Ricci F; Stagi S; Messa F; de Martino M
J Neonatal Perinatal Med; 2018; 11(4):423-425. PubMed ID: 30149478
[TBL] [Abstract][Full Text] [Related]
9. Vanishing bile duct syndrome related to DILI and Hodgkin lymphoma overlap: A rare and severe case.
Greca RD; Cunha-Silva M; Costa LBE; Costa JGF; Mazo DFC; Sevá-Pereira T; Nascimento MMC; Pereira IE; Oliveira FC; Faria GAS; Neto FLP; Almeida JRS
Ann Hepatol; 2020; 19(1):107-112. PubMed ID: 31537508
[TBL] [Abstract][Full Text] [Related]
10. Hepatic GVHD after HLA-haploidentical bone marrow transplantation in children with severe combined immunodeficiency: the effect of ursodeoxycholic acid.
Wulffraat NM; Haddad E; Benkerrou M; Spliet WG; Patey N; Fischer A; de Graeff-Meeder BR
Br J Haematol; 1997 Mar; 96(4):776-80. PubMed ID: 9074421
[TBL] [Abstract][Full Text] [Related]
11. Nivolumab-induced large-duct cholangiopathy treated with ursodeoxycholic acid and tocilizumab.
Reddy CA; Schneider BJ; Brackett LM; Tai AW
Immunotherapy; 2019 Dec; 11(18):1527-1531. PubMed ID: 31789069
[TBL] [Abstract][Full Text] [Related]
12. Biliary microlithiasis.
Menon S
Gastrointest Endosc; 2009 May; 69(6):1197-8; author reply 1198. PubMed ID: 19410059
[No Abstract] [Full Text] [Related]
13. [Hepatobiliary disease in cystic fibrosis].
Pérez-Aguilar F; Berenguer Lapuerta J
Med Clin (Barc); 1998 Sep; 111(8):302-6. PubMed ID: 9810550
[No Abstract] [Full Text] [Related]
14. Delayed postnatal presentation of biliary atresia in 2 premature neonates.
Mourier O; Franchi-Abella S; Ackermann O; Branchereau S; Gonzales E; Bernard O; Jacquemin E
J Pediatr Gastroenterol Nutr; 2011 Apr; 52(4):489-91. PubMed ID: 21407106
[No Abstract] [Full Text] [Related]
15. Primary biliary cirrhosis.
Kaplan MM; Gershwin ME
N Engl J Med; 2005 Sep; 353(12):1261-73. PubMed ID: 16177252
[No Abstract] [Full Text] [Related]
16. Drug-associated acute-onset vanishing bile duct and Stevens-Johnson syndromes in a child.
Srivastava M; Perez-Atayde A; Jonas MM
Gastroenterology; 1998 Sep; 115(3):743-6. PubMed ID: 9721172
[TBL] [Abstract][Full Text] [Related]
17. Hepatic graft-versus-host disease resembling acute hepatitis: additional treatment with ursodeoxycholic acid.
Chiba T; Yokosuka O; Kanda T; Fukai K; Imazeki F; Saisho H; Nishimura M; Saito Y
Liver; 2002 Dec; 22(6):514-7. PubMed ID: 12445178
[TBL] [Abstract][Full Text] [Related]
18. [Biliary cast syndrome in non-liver surgery patients].
Ha SI; Choi JS; Kim YH; Jun HS; Jo YG; Lee WH; Park SG; Lee SH
Korean J Gastroenterol; 2012 Dec; 60(6):382-5. PubMed ID: 23242023
[TBL] [Abstract][Full Text] [Related]
19. Histopathological study of primary biliary cirrhosis and the effect of ursodeoxycholic acid treatment on histology progression.
Degott C; Zafrani ES; Callard P; Balkau B; Poupon RE; Poupon R
Hepatology; 1999 Apr; 29(4):1007-12. PubMed ID: 10094939
[TBL] [Abstract][Full Text] [Related]
20. Vanishing bile duct syndrome: amoxicillin-clavulanic acid associated intra-hepatic cholestasis responsive to ursodeoxycholic acid.
Smith LA; Ignacio JR; Winesett MP; Kaiser GC; Lacson AG; Gilbert-Barness E; González-Peralta RP; Wilsey MJ
J Pediatr Gastroenterol Nutr; 2005 Oct; 41(4):469-73. PubMed ID: 16205517
[No Abstract] [Full Text] [Related]
[Next] [New Search]
